News on QD Group from BioPortfolio.com http://www.BioPortfolio.com Consolidated QD Group news from BioPortfolio.com Wed, 10 Feb 2010 07:42:42 GMT en How to brush your pet's teeth (PDF)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018632&HITNO=0&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018632&THISHREF=http://c.moreover.com/click/here.pl%3fz2525841352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018632&HITNO=0&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018632&THISHREF=http://c.moreover.com/click/here.pl%3fz2525841352%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comThomson Veterinary Healthcare Communications: Life Sciences: New life sciences study findings have been reported from Korea Research Institute of Bioscience and Biotechnologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010505&HITNO=1&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010505&THISHREF=http://c.moreover.com/click/here.pl%3fz2522491914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010505&HITNO=1&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010505&THISHREF=http://c.moreover.com/click/here.pl%3fz2522491914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: NeuroSearch announces positive top-line results from Phase III Huntexil study in Huntington's disease (the Merhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010030&HITNO=2&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010030&THISHREF=http://c.moreover.com/click/here.pl%3fz2522202807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010030&HITNO=2&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010030&THISHREF=http://c.moreover.com/click/here.pl%3fz2522202807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: NeuroSearch Announces Positive Top-line Results From Phase III Huntexil(R) Study in Huntington's Disease (the MermaiHDhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003596&HITNO=3&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003596&THISHREF=http://c.moreover.com/click/here.pl%3fz2519599682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003596&HITNO=3&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003596&THISHREF=http://c.moreover.com/click/here.pl%3fz2519599682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Neurosearch A/S (NEUR.CO) Announces Positive Top-line Results from Phase III Huntexil(R) Study in Huntington'shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007139&HITNO=4&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007139&THISHREF=http://c.moreover.com/click/here.pl%3fz2521020392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007139&HITNO=4&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007139&THISHREF=http://c.moreover.com/click/here.pl%3fz2521020392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Neurosearch A/S (DK:NEUR) Announces Positive Top-line Results from Phase III Huntexil(R) Study in Huntington'shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006004&HITNO=5&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006004&THISHREF=http://c.moreover.com/click/here.pl%3fz2520563898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006004&HITNO=5&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006004&THISHREF=http://c.moreover.com/click/here.pl%3fz2520563898%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: NeuroSearch announces positive top-line results from Phase III Huntexil study in Huntington's disease (the MermaiHD study)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003429&HITNO=6&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003429&THISHREF=http://c.moreover.com/click/here.pl%3fz2519488809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003429&HITNO=6&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003429&THISHREF=http://c.moreover.com/click/here.pl%3fz2519488809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: New data from Astellas Pharma, Inc. illuminate research in pharmacokineticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001747&HITNO=7&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001747&THISHREF=http://c.moreover.com/click/here.pl%3fz2518552141%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001747&HITNO=7&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001747&THISHREF=http://c.moreover.com/click/here.pl%3fz2518552141%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Pharmacokinetics: New data from Astellas Pharma, Inc. illuminate research in pharmacokineticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995657&HITNO=8&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995657&THISHREF=http://c.moreover.com/click/here.pl%3fz2515808192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995657&HITNO=8&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995657&THISHREF=http://c.moreover.com/click/here.pl%3fz2515808192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Axon Expands in the UShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969437&HITNO=9&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969437&THISHREF=http://c.moreover.com/click/here.pl%3fz2500828839%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3969437&HITNO=9&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3969437&THISHREF=http://c.moreover.com/click/here.pl%3fz2500828839%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Nilotinib May Best Imatinib in 1st-line Treathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971375&HITNO=10&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971375&THISHREF=http://c.moreover.com/click/here.pl%3fz2501836512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3971375&HITNO=10&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3971375&THISHREF=http://c.moreover.com/click/here.pl%3fz2501836512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Practice News: Synthesis of ternary CuInS2/ZnS quantum dot bioconjugates and their applications for targeted cancer bioimaginhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951774&HITNO=11&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951774&THISHREF=http://c.moreover.com/click/here.pl%3fz2490399740%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951774&HITNO=11&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951774&THISHREF=http://c.moreover.com/click/here.pl%3fz2490399740%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRSC: Scientists at University of Munich describe research in molecular therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948428&HITNO=12&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948428&THISHREF=http://c.moreover.com/click/here.pl%3fz2488570687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3948428&HITNO=12&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3948428&THISHREF=http://c.moreover.com/click/here.pl%3fz2488570687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: DTE Energy's $3 Million Investment in QD Visionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945729&HITNO=13&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945729&THISHREF=http://c.moreover.com/click/here.pl%3fz2487291952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945729&HITNO=13&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945729&THISHREF=http://c.moreover.com/click/here.pl%3fz2487291952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Ardea Biosciences Reports Positive Results for RDEA594, its Lead Product Candidate for Gout, in Combination wihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919585&HITNO=14&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919585&THISHREF=http://c.moreover.com/click/here.pl%3fz2473559055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3919585&HITNO=14&MSIZE=50&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=QD%20Group&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3919585&THISHREF=http://c.moreover.com/click/here.pl%3fz2473559055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKOTA Territory News: